Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era

Leukemia and Lymphoma

Volumn 55, Issue 3, 2014, Pages 551-557

  Morton, Lindsay M ^a   Kim, Clara J ^a   Weiss, Lawrence M ^b   Bhatia, Kishor ^a   Cockburn, Myles ^c   Hawes, Debra ^c   Wang, Sophia S ^b   Chang, Cindy ^a   Altekruse, Sean F ^a   Engels, Eric A ^a   Cozen, Wendy ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Activated B cell; Diffuse large B cell lymphoma; Epstein Barr virus; Germinal center B cell

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GERMINAL CENTER; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84894463186     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.813499     Document Type: Article

References (36)

1. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2008, Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/19752008/. 2011
2. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511
3. Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003;198:851-862
4. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-1947
5. Lenz G, Wright GW, Emre NC, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 2008;105:13520-13525
6. Pasqualucci L, Trifonov V, Fabbri G, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011;43: 830-837
7. Schneider C, Pasqualucci L, Dalla-Favera R. Molecular pathogenesis of diffuse large B-cell lymphoma. Semin Diagn Pathol 2011;28:167-177
8. Knowles DM. Etiology and pathogenesis of AIDS-related non- Hodgkin's lymphoma. Hematol Oncol Clin North Am 2003;17: 785-820
9. Moir 5, Fauci AS. B cells in HW infection and disease. Nat Rev Immunol 2009;9:235-245
10. Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006;20:1645-1654
11. Carbone A, Cesarman E, Spina M, et al. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009;1 13:1213-1224
12. Deffenbacher ICE, Iqbal J, Liu Z, et al. Recurrent chromosomal alterations in molecularly classified AIDS-related lymphomas: an integrated analysis of DNA copy number and gene expression. JAcquir Immune Defic Syndr 2010;54:18-26
13. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 2001;97:744-751
14. Capello D, Martini M, Gloghini A, et al. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus- related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis. Haematologica 2008;93:1178-1185
15. Delecluse HJ, Hummel M, Marafioti I, et al. Common and HWrelated diffuse large B-cell lymphomas differ in their immunoglobulin gene mutation pattern. J Pathol 1999;188:133-138
16. Kurosu K, Weiden MD, Takiguchi Y, et al. BCL-6 mutations in pulmonary lymphoproliferative disorders: demonstration of an aberrant immunological reaction in HW-related lymphoid interstitial pneumonia. J Immunol 2004;172:71 16-7122
17. ChadburnA, ChiuA, LeeJY, et al. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol 2009;27:5039-5048
18. Hoffmann C, Tiemann M, Schrader C, et al. AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping. Blood 2005;106:1762-1769
19. Xicoy B, Ribera JM, Mate JL, et al. Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infection. Leuk Lymphoma 2010;51:2063-2069
20. Vilchez RA, Lopez-Terrada D, Middleton JR, et al. Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS- related non-Hodgkin's lymphoma. Virology 2005;342:38-46
21. Little lIP, Pittaluga 5, Grant N, et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 2003;101:4653-4659
22. Dunleavy K, Little RF, Pittaluga 5, et al. The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood 2010;115:3017-3024
23. Klein U, Gloghini A, Gaidano G, et al. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 2003; 10 1:4115-412 1
24. Madan R, Gormley R, Dulau A, et al. AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles. Mod Pathol 2006; 19:438-446
25. Meyer PN, Fu IC, Greiner TC, et al. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol 201 1;29:200-207
26. Goodman MT, Hernandez BY, Hewitt 5, et al. Tissues from population-based cancer registries: a novel approach to increasing research potential. Hum Pathol 2005;36:812-820
27. Chang K, Chen Y-Y, Shibata D, et al. In situ hybridization methodology for the detection of EBV EBER-1 RNA in paraffin- embedded tissues, as applied to normal and neoplastic tissues. Diagn Mol Pathol 1992;1:246-255
28. Bedell \4 Forman 5, Gaal IC, et al. Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections. J Mol Diagn 2007;9:589-597
29. Carbone A, Gaidano G, GloghiniA, et al. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-i expression. Am J Pathol 1997;150:155-165
30. Martin-Perez D, Vargiu P, Montes-Moreno 5, et al. Epstein- Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma. Leukemia 2012;26:180-183
31. Finke J, Fritzen R, Ternes P, et al. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood 1992;80:459-469
32. Henderson 5, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991;65: 1107-1115
33. Iqbal J, Greiner TC, Patel IC, et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia 2007;21: 2332-2343
34. Biggar RJ, Chaturvedi AIC, Goedert JJ, Engels EA. AIDS-related cancer and severity of immunosuppression in persons with AIDS. Natl Cancer Inst 2007;99:962-972
35. Gutierrez-Garcia G, Cardesa-Salzmann T, Climent F, et al. Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood 2011;117:4836-4843
36. de Jong D, Xie W, Rosenwald A, et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium). J Clin Pathol 2009;62:128-138.